Studies

CellWell record HH-120002

Pharmacological Management, Safety, and Outcomes in Bipolar Disorder: An Integrated Narrative Review of Clinical and Translational Evidence

Gudisa Bereda

2026

In plain language

Lithium and combination therapies improved bipolar disorder relapse prevention, cognitive outcomes, and mortality despite poor medication adherence and monitoring compliance. Sleep disturbances associated with poorer functional outcomes requiring integrated monitoring strategies.

Evidence
Emerging
Design
Expert review

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-120002

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.